A.R.T. Advisors’s Idexx Laboratories IDXX Stock Holding History

A.R.T. Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-958	Closed	-$250K	–	498
2019 Q4	$250K	Buy	+958	New	+$252K	0.01%	1087
2018 Q3	–	Sell	-6,200	Closed	-$1.35M	–	1529
2018 Q2	$1.35M	Buy	+6,200	New	+$1.28M	0.06%	507
2018 Q1	–	Sell	-13,300	Closed	-$2.08M	–	1621
2017 Q4	$2.08M	Buy	+13,300	New	+$2.09M	0.09%	361
2017 Q3	–	Sell	-2,200	Closed	-$355K	–	1486
2017 Q2	$355K	Sell	2,200 -13,600	-86%	-$2.21M	0.02%	947
2017 Q1	$2.44M	Buy	15,800 +6,300	+66%	+$868K	0.11%	252
2016 Q4	$1.11M	Buy	9,500 +7,200	+313%	+$822K	0.07%	446
2016 Q3	$259K	Sell	2,300 -1,815	-44%	-$191K	0.08%	398
2016 Q2	$382K	Buy	+4,115	New	+$353K	0.02%	887
2015 Q1	–	Sell	-12,076	Closed	-$895K	–	1542
2014 Q4	$895K	Sell	12,076 -38,350	-76%	-$2.69M	0.03%	693
2014 Q3	$2.97M	Buy	+50,426	New	+$3.19M	0.14%	210
2014 Q1	–	Sell	-29,892	Closed	-$1.59M	–	1432
2013 Q4	$1.59M	Buy	+29,892	New	+$1.57M	0.08%	349

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

A.R.T. Advisors's IDXX Position: Q1 2020 in Review

A.R.T. Advisors sold out of Idexx Laboratories (IDXX) in Q1 2020, closing a stake of 958 shares — an estimated $250K sold.

A.R.T. Advisors first reported a position in IDXX in Q4 2013 and held it in 11 quarters. The position peaked at $2.97M in Q3 2014. 748 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

A.R.T. Advisors reported no remaining Idexx Laboratories position as of Q1 2020 after selling out during the quarter.
A.R.T. Advisors sold 958 Idexx Laboratories shares in Q1 2020, an estimated $250K.
A.R.T. Advisors first reported a position in Idexx Laboratories in Q4 2013 and held it in 11 quarters.
A.R.T. Advisors's Idexx Laboratories position peaked at $2.97M in Q3 2014.
748 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.